Peripheral arterial disease (PAD) occurs when leg arteries become narrowed or blocked by plaque. These blockages can result in severe pain for patients, limited physical mobility, and life-threatening non-healing leg ulcers. According to the American Heart Association, this condition affects approximately 8 to 12 million Americans. With only about 25 percent of PAD patients undergoing treatment, it is a disease that is largely under-diagnosed and under-treated. If left untreated, PAD can lead to critical leg ischemia, a condition where not enough blood is being delivered to the leg to keep the tissue alive. Total loss of circulation to the legs and feet can cause gangrene and lead to amputation.
Patients with peripheral arterial disease (PAD) are more likely to have a foot or leg amputated if they live in a region that has few vascular surgeons, according to a Rice University/Baylor College of Medicine study published in the July issue of the Journal of Vascular Surgery.
The first patient undergoes treatment today in a new prospective randomised trial, called the SUPER Study, to compare stenting with balloon angioplasty in patients with superficial femoral artery (SFA) occlusions caused by peripheral artery disease (PAD).
For several years, crippling leg pain has prevented Joan Erickson from walking more than a block. If she paused to rest, she could walk a little more, but not enough to continue playing golf, her favorite pastime.
A study published today in the journal Critical Care shows that a brief training session is all that is needed for safe and efficient use of an automated external defibrillator.
Serono has announced that it has completed enrollment in its second multi-center, phase III trial of Serostim (somatropin [rDNA origin] for injection) in the treatment of HIV-Associated Adipose Redistribution Syndrome (HARS).
Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.
Vasogen today announced that it has reached full enrollment in its 500-patient pivotal phase III SIMPADICO trial of Celacade (immune modulation therapy) for the treatment of peripheral arterial disease (PAD).
The survey of 1,014 U.S. adults revealed some vivid findings including the fact that people suffering from back pain are dealing with the issue an average of 14 days per month and often don't seek the advice of trained professionals to treat or improve their condition.
By using a device only six-millionths of a meter long, researchers at Cornell University have been able to detect the presence of as few as a half-dozen viruses -- and they believe the device is sensitive enough to notice just one.
International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology’s 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.
A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.
An under-recognized and usually asymptomatic condition called subclavian artery stenosis – an obstruction of arteries located under the clavicle, or collarbone – is important in the diagnosis and treatment of high blood pressure
Vascular Disease Foundation spearheads new national, multidisciplinary organization to educate patients, clinicians on peripheral arterial disease (PAD).
The presence and severity of peripheral arterial disease, as measured by comparing blood pressures in the arm and leg, and the nature of the leg symptoms a patient experiences can be used to identify those at highest risk of decline in walking endurance, according to a study in the July 28 issue of JAMA, the Journal of the American Medical Association.
"These actions will expand even further the availability of a simple, rapid HIV test to communities where people are at high risk of HIV," Secretary Thompson said. "HIV testing has never been easier or more accessible than it is today.
To help parents and their children understand and fully appreciate the importance of sleep, the National Institutes of Health’s (NIH) Office of Science Education and National Heart, Lung, and Blood Institute (NHLBI) have developed a new supplemental curriculum for use in high school biology classes.
An Austrian study has found that smoking cigarettes, a habit that contributes to the development of peripheral artery disease-actually helps arteries stay open following a procedure to repair clogged blood vessels in the legs. The study found that habitual to heavy smokers who continued to smoke after angioplasty had a lower rate of restenosis, or re-narrowing of the arteries, than nonsmokers.
The University of Arizona Medical Center for the first time will be part of a national effort to detect life-threatening non-cardiac vascular diseases. UMC is partnering with the American Vascular Association to offer free screenings for people at high risk: 60 years or older with a history of hypertension, diabetes, smoking, high cholesterol, or known cardiovascular disease.
HEEL that PAIN is a joint venture between GID Development Corp. and Dr. Art Smuckler, a certified podiatrist. After developing a few customized foot-pads for patients complaining of persistent heel pain, Smuckler wanted to share the benefits of these foot pads with the mass market.
Nightmares of doctors or dentists with oversized hypodermic needles could soon be a thing of the past. A new painless way of delivering drugs through the skin is described in the journal BMC Medicine this week – and needles are not involved.